Sorafenib Superior to Sunitinib in Overall Survival in Advanced Hepatocellular Carcinoma - ONA

Links shared publicly online about this topic.

236
total visits

Sorafenib Superior to Sunitinib in Overall Survival in Advanced Hepatocellular Carcinoma - ONA

Sunitinib was not found to be effective in improving overall survival in patients with advanced hepatocellular carcinoma compared with sorafenib, according to data reported at the American Society of Clinical Oncology’s 2011 Annual Meeting. However, progression-free survival and time to progression were similar for sunitinib and sorafenib.

View full resource at oncologynurseadvisor.com

Tags: Cancer, Liver Cancer